• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子在住院COVID-19患者中的预后效用

The Prognostic Utility of Cytokines in Hospitalized COVID-19 Patients.

作者信息

Andrejkovits Ákos Vince, Huțanu Adina, Susányi Ervin József, Negrea Valentina, Văsieșiu Anca Meda

机构信息

Doctoral School of Medicine and Pharmacy, I.O.S.U.D., George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania.

Department of Laboratory Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania.

出版信息

J Crit Care Med (Targu Mures). 2023 Nov 14;9(4):208-217. doi: 10.2478/jccm-2023-0025. eCollection 2023 Oct.

DOI:10.2478/jccm-2023-0025
PMID:37969879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10644278/
Abstract

INTRODUCTION

The severity of COVID-19 relies on several factors, but the overproduction of pro-inflammatory cytokines remains a central mechanism. The aim of this study was to investigate the predictive utility of interleukin (IL)-6, IL-8, IL-10, IL-12, tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) measurement in patients with COVID-19.

MATERIAL AND METHODS

We prospectively enrolled 181 adult patients with COVID-19 admitted to the 1 Infectious Disease County Hospital Târgu Mureș from December 2020 to September 2021. Serum cytokine levels were measured and correlated with disease severity, need for oxygen therapy, intensive care unit (ICU) transfer, and outcome.

RESULTS

We found significantly higher serum levels of IL-6, IL-8, and IL-10 in patients with severe COVID-19 and in those with a fatal outcome. The logistic regression analysis showed a significant predictive value for IL-8 regarding disease severity, and for IL6 and IL-10 regarding ICU transfer and fatal outcome.

CONCLUSIONS

Serum levels of IL-6, IL-8, and IL-10 were significantly increased in patients with COVID-19, but their predictive value regarding disease severity and the need for oxygen therapy was poor. We found IL-6 and IL-10 to have a good predictive performance regarding ICU transfer and fatal outcome.

摘要

引言

新型冠状病毒肺炎(COVID-19)的严重程度取决于多种因素,但促炎细胞因子的过度产生仍然是核心机制。本研究的目的是探讨白细胞介素(IL)-6、IL-8、IL-10、IL-12、肿瘤坏死因子α(TNF-α)和干扰素γ(IFN-γ)检测对COVID-19患者的预测效用。

材料与方法

我们前瞻性纳入了2020年12月至2021年9月在特尔古穆列什县第一传染病医院住院的181例成年COVID-19患者。检测血清细胞因子水平,并将其与疾病严重程度、氧疗需求、重症监护病房(ICU)转诊及预后相关联。

结果

我们发现重症COVID-19患者及死亡患者的血清IL-6、IL-8和IL-10水平显著更高。逻辑回归分析显示,IL-8对疾病严重程度具有显著预测价值,IL-6和IL-10对ICU转诊和死亡结局具有显著预测价值。

结论

COVID-19患者的血清IL-6、IL-8和IL-10水平显著升高,但其对疾病严重程度和氧疗需求的预测价值较差。我们发现IL-6和IL-10对ICU转诊和死亡结局具有良好的预测性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd4/10644278/73f7290ef47d/j_jccm-2023-0025_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd4/10644278/4f61eef933e8/j_jccm-2023-0025_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd4/10644278/73f7290ef47d/j_jccm-2023-0025_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd4/10644278/4f61eef933e8/j_jccm-2023-0025_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd4/10644278/73f7290ef47d/j_jccm-2023-0025_fig_002.jpg

相似文献

1
The Prognostic Utility of Cytokines in Hospitalized COVID-19 Patients.细胞因子在住院COVID-19患者中的预后效用
J Crit Care Med (Targu Mures). 2023 Nov 14;9(4):208-217. doi: 10.2478/jccm-2023-0025. eCollection 2023 Oct.
2
Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis.急性重症胰腺炎期间的促炎和抗炎细胞因子:一种早期且持续的反应,尽管对死亡的预测性不佳。巴黎急性胰腺炎研究小组
Crit Care Med. 1999 Apr;27(4):749-55. doi: 10.1097/00003246-199904000-00029.
3
Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.血清 IL-23、IL-10 和 TNF-α 可预测 COVID-19 患者的住院死亡率。
Front Immunol. 2023 May 22;14:1145840. doi: 10.3389/fimmu.2023.1145840. eCollection 2023.
4
Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases.分析轻、重症 COVID-19 患者鼻咽环境中促炎细胞因子的差异基因表达。
PLoS One. 2022 Dec 30;17(12):e0279270. doi: 10.1371/journal.pone.0279270. eCollection 2022.
5
Influence of SARS-COV-2 Infection on Cytokine Production by Mitogen-Stimulated Peripheral Blood Mononuclear Cells and Neutrophils in COVID-19 Intensive Care Unit Patients.新型冠状病毒肺炎重症监护病房患者中,严重急性呼吸综合征冠状病毒2感染对丝裂原刺激的外周血单个核细胞和中性粒细胞产生细胞因子的影响
Microorganisms. 2022 Nov 4;10(11):2194. doi: 10.3390/microorganisms10112194.
6
Characterization of the inflammatory response to COVID-19 illness in pregnancy.探讨 COVID-19 疾病在妊娠期间引发的炎症反应特征。
Cytokine. 2023 Oct;170:156319. doi: 10.1016/j.cyto.2023.156319. Epub 2023 Aug 4.
7
Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.在住院患者中,COVID-19 感染严重程度期间 IFN-γ 的表达显著降低。
PLoS One. 2023 Sep 27;18(9):e0291332. doi: 10.1371/journal.pone.0291332. eCollection 2023.
8
Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.细胞因子和脂肪因子谱对住院 COVID-19 患者的预测作用:疾病严重程度、生存和肺部后遗症的评估。
Int J Mol Sci. 2023 Aug 20;24(16):12994. doi: 10.3390/ijms241612994.
9
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial.住院 COVID-19 患者的通气支持和炎症肽:一项前瞻性队列研究。
PLoS One. 2023 Nov 2;18(11):e0293532. doi: 10.1371/journal.pone.0293532. eCollection 2023.
10
Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.与秘鲁 COVID-19 住院患者预后较差相关的细胞因子谱。
Front Immunol. 2021 Sep 1;12:700921. doi: 10.3389/fimmu.2021.700921. eCollection 2021.

引用本文的文献

1
COVID-19 and Carcinogenesis: Exploring the Hidden Links.新冠病毒与致癌作用:探索潜在联系
Cureus. 2024 Aug 31;16(8):e68303. doi: 10.7759/cureus.68303. eCollection 2024 Aug.
2
Expression of Interleukin-8, Interleukin-12 and Interleukin-13 in Esophageal Squamous Cell Carcinoma: Biomarker Potentiality and Prognostic Significance.白细胞介素-8、白细胞介素-12 和白细胞介素-13 在食管鳞状细胞癌中的表达:生物标志物潜力和预后意义。
J Gastrointest Cancer. 2024 Sep;55(3):1239-1255. doi: 10.1007/s12029-024-01063-1. Epub 2024 Jun 23.

本文引用的文献

1
Prediction of prognosis in patients with severe COVID-19 pneumonia using CT score by emergency physicians: a single-center retrospective study.利用急诊医师 CT 评分预测重症 COVID-19 肺炎患者的预后:一项单中心回顾性研究。
Sci Rep. 2023 Mar 10;13(1):4045. doi: 10.1038/s41598-023-31312-5.
2
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome.与急性 COVID-19 和长新冠综合征相关的细胞因子谱。
Front Cell Infect Microbiol. 2022 Jun 30;12:922422. doi: 10.3389/fcimb.2022.922422. eCollection 2022.
3
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.
COVID-19 与合并症:风险、协同作用和临床结局。
Front Immunol. 2022 May 27;13:890517. doi: 10.3389/fimmu.2022.890517. eCollection 2022.
4
Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study.COVID-19 与其他呼吸道感染的炎症生物标志物的临床实用性比较:一项前瞻性队列研究。
PLoS One. 2022 May 27;17(5):e0269005. doi: 10.1371/journal.pone.0269005. eCollection 2022.
5
COVID-19 infection: an overview on cytokine storm and related interventions.COVID-19 感染:细胞因子风暴及相关干预措施概述。
Virol J. 2022 May 26;19(1):92. doi: 10.1186/s12985-022-01814-1.
6
COVID-19 and the role of cytokines in this disease.新型冠状病毒肺炎(COVID-19)以及细胞因子在该疾病中的作用。
Inflammopharmacology. 2022 Jun;30(3):789-798. doi: 10.1007/s10787-022-00992-2. Epub 2022 May 4.
7
A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.COVID-19 中的细胞因子谱和降钙素原:重症监护与非重症监护患者的比较。
PLoS One. 2022 May 2;17(5):e0266652. doi: 10.1371/journal.pone.0266652. eCollection 2022.
8
The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome.白细胞介素-8在肺部炎症和损伤中的作用:对2019冠状病毒病及高炎症性急性呼吸窘迫综合征治疗的启示
Front Pharmacol. 2022 Jan 12;12:808797. doi: 10.3389/fphar.2021.808797. eCollection 2021.
9
Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude.比较海平面和高海拔地区 COVID-19 患者的细胞因子水平。
BMC Infect Dis. 2022 Jan 28;22(1):96. doi: 10.1186/s12879-022-07079-x.
10
Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation.严重的 COVID-19 的特征是中等程度的细胞因子炎症和严重的单核细胞失调同时发生。
EBioMedicine. 2021 Nov;73:103622. doi: 10.1016/j.ebiom.2021.103622. Epub 2021 Oct 20.